Germany· DE-A57-2223975fd3b78d79
Telmiinda Apontis
A medicinal product containing indapamide, telmisartan, registered in Germany by Krka, D.D., Novo Mesto.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Indapamide, Telmisartan
- Manufacturer
- Krka, D.D., Novo Mesto
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Indapamide, telmisartan in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaTEDENOMOKrka, d.d., Novo mesto, Novo mesto
- PolandTolurindoKrka, d.d., Novo mesto
- FinlandYlpioPro.Med.Cs Praha a.s.
- NetherlandsYLPIO 80 mg/2,5 mg tablettenPRO.MED.CS Praha a.s.
Authorised across Europe · EMA
The same active substance is authorised in 17 EEA countries. Names it is sold under:
- Belgium · Ylpio
- Bulgaria · Толмидуо
- Cyprus · Tolmiduo
- Czechia · Tedenomo, Telmisartan/Indapamid Pmcs
- Estonia · Tolurindo
- Finland · Ylpio
- Croatia · Tolurindo
- Hungary · Tedenomo, Telmisartan/Indapamid Krka
- Lithuania · Ilpio, Tolmiduo
- Luxembourg · Ylpio
- Latvia · Ilpio, Tolurindo
- Netherlands · Ylpio
- Poland · Tolurindo, Ylpio
- Portugal · Tolurindo
- Romania · Tolmiduo, Ylpio
- Slovenia · Tolupind
- Slovakia · Tolupind, Ylpio
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b5f1c824-d466-48f7-a84e-6671e5283eba GET /v1/drugs/b5f1c824-d466-48f7-a84e-6671e5283eba?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Indapamide, Telmisartan",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about indapamide, telmisartan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.